更快地进行概念验证

Faster paths to proof of concept: How biotech companies approach acceleration 1 Accelerating clinical development is a priority across the biopharma industry, but the pressure for speed is often most intense among small and mid-sized biotechs. While their leanness allows them to respond with agility to shifting landscapes, it also makes them susceptible to significant financial risk. By reaching proof of concept as efficiently as possible, biotechs can make the best use of their resources, putting expertise ...